#6675 on the rich list of 14,644 insiders
Robert J. Alpern
Director at AbbVie; Director at Abbott Laboratories. Based in North Chicago, Illinois.
$14.3M
in disclosed stock, −$113K (−0.78%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 6675th of 14,644
- Companies held
- 2
- Largest holding
- ABBV, 70.5% of total
- Latest SEC filing
- May 9, 2025
What the $14.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| AbbVie ABBV Common Stock, $0.01 par value | Directly | 35,646 | $283.54 | $10.1M | 70.5% | Form 4, May 9, 2025 |
| Abbott Laboratories ABT Common shares without par value | Directly | 40,798 | $103.87 | $4.2M | 29.5% | Form 4, Apr 25, 2025 |
Share counts are the amounts Robert J. Alpern reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6672 | Darren King Sr. Executive Vice President, M&T Bank. Cincinnati, OH | $14.4M |
| 6673 | Mark J. Foley Director, Glaukos. Aliso Viejo, CA | $14.3M |
| 6674 | Jamie E. Haenggi Exec. Vice President, Solar, ADT. Fremont, CA | $14.3M |
| 6675 | Robert J. Alpern Director, AbbVie. North Chicago, IL | $14.3M |
| 6676 | Rodger Levenson President & CEO, WSFS Financial. Wilmington, DE | $14.3M |
| 6677 | Gavin Hattersley President & CEO, Molson Coors Beverage. Hunt Valley, MD | $14.3M |
| 6678 | Julia G. Butchko Chief Development Officer, Immunovant. New York, NY | $14.3M |
Other AbbVie insiders
All ABBV insiders- Richard A. Gonzalez$110MDirector. #1415 overall
- Laura J. Schumacher$70.3MVice Chairman. #1699 overall
- Azita Saleki$60.9MEVP, CHIEF OPERATIONS OFFICER. #2124 overall
- Henry O. Gosebruch$51.2MEVP, Chief Strategy Officer. #2475 overall
- Robert A. Michael$50.7MCHAIRMAN OF THE BOARD AND CEO. #2517 overall
- Michael Severino$43.1MVice Chairman. #2349 overall
Questions
How much stock does Robert J. Alpern own?
Robert J. Alpern holds $14,344,755 in listed stock based on SEC filings and current prices, mostly AbbVie (ABBV). That ranks 6675th on the Stock Rich List.
Is this Robert J. Alpern's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.